FTR - SSNC and PBI among premarket losers May, 01 2019 09:19 AM Frontier Communications Corporation Heron Therapeutics (NASDAQ:HRTX) -24% after FDA rejects application for pain med HTX-011.More news on: Heron Therapeutics, Inc., Nabriva Therapeutics plc, CM Seven Star Acquisition Corporation, Stocks on the move, Read more ...